This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 11, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended
June 30, 2013 on
Thursday, July 25, at
8:00 a.m. ET.
The call will be hosted by
Michael Mahoney, president and chief executive officer, and
Jeff Capello, executive vice president and chief financial officer.
A live webcast of the conference call will be available via the Boston Scientific website. Webcast registration is available on the Investor Relations section of the website at
www.bostonscientific.com/investors. Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations:
www.earnings.com, which is accessible to the public, and
www.streetevents.com, a password-protected event management site.
An archived replay of the webcast will be accessible at
www.bostonscientific.com/investors approximately one hour following the completion of the conference call and available for approximately one year.
The company will issue a news release announcing financial results for the second quarter on
Thursday, July 25, prior to the conference call.
About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on
Peter Lucht508-650-8796 (office)Global Corporate CommunicationsBoston Scientific Corporation
email@example.comMichael Campbell508-650-8023 (office)Investor RelationsBoston Scientific Corporation
SOURCE Boston Scientific Corporation